— Know what they know.
Not Investment Advice
Also trades as: CLNNW (NASDAQ) · $vol 0M

CLNN NASDAQ

Clene Inc.
1W: -3.5% 1M: -0.2% 3M: -30.9% YTD: -28.1% 1Y: -40.5% 3Y: -60.7% 5Y: -97.1%
$4.08
+0.06 (+1.49%)
 
Weekly Expected Move ±14.7%
$3 $4 $4 $5 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 42 · $52.1M mcap · 10M float · 1.02% daily turnover · Short 25% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$200K -41.5% ▼
5Y CAGR: -0.6%
Gross Profit
$157K -42.3% ▼
5Y CAGR: +2.2%
Operating Income
-$23M +30.2% ▲
Net Income
-$26M +33.6% ▲
EPS (Diluted)
$-2.65 +53.3% ▲
EBITDA
-$22M +35.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$723K$473K$654K$342K$200K
YoY Growth+251.0%-34.6%+38.3%-47.7%-41.5%
Cost of Revenue$289K$26K$121K$70K$43K
Gross Profit$434K$447K$533K$272K$157K
Gross Margin60.0%94.5%81.5%79.5%78.5%
R&D Expenses$28M$32M$27M$20M$14M
SG&A Expenses$19M$16M$14M$13M$9M
Operating Expenses$50M$49M$41M$33M$23M
Operating Income-$50M-$48M-$41M-$33M-$23M
Operating Margin-6912.6%-10234.5%-6198.8%-9676.3%-11541.5%
Interest Expense$870K$3M$5M$4M$3M
Income Before Tax-$10M-$30M-$50M-$39M-$26M
Tax Expense-$428K$0$0$0$0
Net Income-$10M-$30M-$50M-$39M-$26M
Net Margin-1347.2%-6325.2%-7569.4%-11520.5%-13086.5%
EPS (Diluted)$-3.16$-4.69$-9.43$-5.67$-2.65
EBITDA-$8M-$26M-$43M-$34M-$22M
Shares Outstanding3M3M5M7M10M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms